Barclays
RPTP

Barclays’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Barclays’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-15,000
Closed -$75K – 6908
2015
Q4 		$75K Hold
15,000
– – ﹤0.01% 4580
2015
Q3 		$90K Buy
+15,000
New +$184K ﹤0.01% 4688

Barclays's RPTP Position: Q4 2016 in Review

Barclays sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 253,084 shares — an estimated $2.27M sold.

Barclays first reported a position in RPTP in Q2 2013 and held it in 13 quarters. The position peaked at $2.27M in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Barclays reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Barclays sold 253,084 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $2.27M.
  • Barclays first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 13 quarters.
  • Barclays's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $2.27M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Barclays's 13F filing for Q4 2016, filed 14 Feb 2017.